SIR ePoster Library

615 - Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials
SIR ePoster library. Brown R. 03/28/20; 289857; 615
Dr. Robert Brown
Dr. Robert Brown
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
Poster Title: Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials

Poster number: 615

Category: Non-Vascular Interventions: Other

Authors: R Brown1, M Imawari2, N Izumi3, Y Osaki4, T Ochiai5, T Kano5, R Bentley6, M Peck-Radosavljevic7

Keywords: 0615, Robert Brown Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials Lusutrombopag is a safe and efficacious treat
Poster Title: Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials

Poster number: 615

Category: Non-Vascular Interventions: Other

Authors: R Brown1, M Imawari2, N Izumi3, Y Osaki4, T Ochiai5, T Kano5, R Bentley6, M Peck-Radosavljevic7

Keywords: 0615, Robert Brown Lusutrombopag is a safe and efficacious treatment option for thrombocytopenia in patients with chronic liver disease undergoing planned invasive procedures: integrated analysis of two phase 3 trials Lusutrombopag is a safe and efficacious treat
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies